SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-057004
Filing Date
2021-11-15
Accepted
2021-11-15 16:10:10
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sndx-10q_20210930.htm   iXBRL 10-Q 2746413
2 EX-10.1 sndx-ex101_182.htm EX-10.1 794735
3 EX-10.2 sndx-ex102_181.htm EX-10.2 116645
4 EX-31.1 sndx-ex311_8.htm EX-31.1 10279
5 EX-31.2 sndx-ex312_7.htm EX-31.2 10724
6 EX-32.1 sndx-ex321_6.htm EX-32.1 11871
  Complete submission text file 0001564590-21-057004.txt   11414627

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA sndx-20210930.xsd EX-101.SCH 56993
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20210930_cal.xml EX-101.CAL 48918
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20210930_def.xml EX-101.DEF 180649
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20210930_lab.xml EX-101.LAB 393415
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20210930_pre.xml EX-101.PRE 293127
12 EXTRACTED XBRL INSTANCE DOCUMENT sndx-10q_20210930_htm.xml XML 2477047
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 211410590
SIC: 2834 Pharmaceutical Preparations